# Propanc Biopharma, Inc.: Form 8-K, filed Aug 19, 2025

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2025-08-19
- Accepted by EDGAR: Aug 19, 2025, 17:24 ET
- Period: 2025-08-14
- Accession: 0001641172-25-024872
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/form8-k.htm

Filed Aug 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-024872. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.